Combined antifungal therapy is superior to monotherapy in pulmonary scedosporiosis in cystic fibrosis

Cystic fibrosis (CF) is characterised by chronic airway infection with bacteria and fungi. Infections caused by Scedosporium/Lomentospora species can occur and are difficult to treat. Moulds belonging to the genus Scedosporium/Lomentospora are detected most frequently in respiratory samples of patients with CF, next to Aspergillus spp. Our aim was to define pulmonary fungal infections due to Scedosporium/Lomentospora in CF and to study the antimycotic treatment.In this multicentre study (12 centres; duration January 2008 to December 2014) 31 patients with a lung infection caused by moulds of the genus Scedosporium/Lomentospora were included.

Source: Journal of Cystic Fibrosis - October 6, 2018 Category: Respiratory Medicine Authors: Carsten Schwarz, Claudia Brandt, Volker Melichar, Christoph Runge, Eberhard Heuer, Hany Sahly, Martin Schebek, Holger K öster, Jean-Philippe Bouchara, Thomas Biedermann, Peter Meißner, Jörg Große-Onnebrink, Heino Skopnik, Dominik Hartl, Ludwig Sedlace Tags: Original Article Source Type: research